VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PBYI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
PBYIPuma Biotechnology, Inc.
$7.22$367M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPBYIQuarterly Financials

Puma Biotechnology, Inc. (PBYI) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Puma Biotechnology, Inc. (PBYI) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

PBYI Income Statement

Quarterly statement

PBYI Income Statement

Puma Biotechnology, Inc. (PBYI) annual income statement — 19-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue55.1M56.5M44.81M75.45M54.48M52.44M46.01M59.08M80.54M47.08M43.77M72.18M56.12M54.57M52.77M65.67M57.1M59.52M45.74M55.36M
Revenue Growth %1.15%7.75%-2.59%27.72%-32.36%11.37%5.12%-18.15%43.53%-13.72%-17.07%9.9%-1.73%-8.32%15.39%18.64%23.48%11.49%-53.41%5.33%
Cost of Goods Sold15.2M12.47M10.42M23.13M12.17M12.3M10.56M13.92M29.1M10.66M10.73M24.32M13.28M11.86M13.22M16.84M12.49M14.92M10.84M11.89M
COGS % of Revenue27.59%22.08%23.26%30.65%22.35%23.46%22.94%23.56%36.13%22.64%24.51%33.7%23.67%21.73%25.05%25.64%21.88%25.06%23.71%21.49%
Gross Profit39.9M44.03M34.39M52.33M42.3M40.13M35.45M45.16M51.45M36.42M33.04M47.85M42.83M42.71M39.56M48.84M44.61M44.6M34.89M43.46M
Gross Margin %72.41%77.92%76.74%69.35%77.65%76.54%77.06%76.44%63.87%77.36%75.49%66.3%76.33%78.27%74.95%74.36%78.12%74.94%76.29%78.51%
Gross Profit Growth %-5.68%9.7%-2.99%15.88%-17.77%10.19%7.3%-5.64%20.11%-14.72%-16.48%-2.01%-3.98%-4.24%13.37%12.37%24.03%7.69%-49.15%4.43%
Operating Expenses34.6M36.44M38.22M35.22M32.73M33.5M31.47M31.79M29.37M38.6M35.34M33.06M34.25M37.82M35.19M38.82M42.21M32.54M35.64M67.05M
OpEx % of Revenue62.79%64.5%85.28%46.68%60.08%63.89%68.4%53.81%36.46%81.99%80.74%45.8%61.03%69.31%66.68%59.11%73.93%54.68%77.92%121.12%
Selling, General & Admin16.3M17.55M18.42M18.38M17.03M18.41M17.39M17.02M16.87M24.97M21.75M20.18M22.18M23.95M22.49M25.04M23.96M20.58M20.4M22.46M
SG&A % of Revenue29.58%31.06%41.11%24.36%31.26%35.11%37.8%28.81%20.94%53.04%49.7%27.96%39.52%43.89%42.61%38.13%41.96%34.57%44.61%40.58%
Research & Development18.3M18.89M19.8M16.84M15.91M15.45M13.86M15.17M12.55M13.63M13.59M12.87M11.45M13.36M12.71M13.78M11.25M11.97M15.24M14.17M
R&D % of Revenue33.21%33.44%44.17%22.32%29.21%29.47%30.13%25.68%15.58%28.95%31.04%17.84%20.4%24.48%24.08%20.99%19.71%20.1%33.32%25.59%
Other Operating Expenses0000-213K-362K213K-398K-48K000625K514K001000K001000K
Operating Income5.3M7.58M-3.83M17.11M9.57M6.64M3.98M13.37M22.08M-2.18M-2.3M14.8M8.59M4.89M4.37M10.02M2.39M12.06M-747K-23.58M
Operating Margin %9.62%13.42%-8.54%22.67%17.57%12.66%8.66%22.62%27.41%-4.63%-5.25%20.5%15.3%8.96%8.27%15.25%4.19%20.26%-1.63%-42.6%
Operating Income Growth %-44.64%14.3%-196.08%27.99%-56.64%404.54%273.29%-9.68%157.18%-144.54%-152.67%47.74%258.75%-59.43%684.34%142.47%126.73%172.49%-103.71%-111.53%
EBITDA5.3M10.1M-1.24M19.76M12.29M9.4M6.78M16.21M24.96M729K598K17.69M11.46M7.77M7.24M12.22M4.86M14.52M1.71M-21.31M
EBITDA Margin %9.62%17.88%-2.78%26.19%22.57%17.92%14.74%27.43%30.99%1.55%1.37%24.5%20.42%14.24%13.72%18.61%8.51%24.39%3.74%-38.5%
EBITDA Growth %-56.89%7.47%-118.35%21.95%-50.74%1189.3%1033.78%-8.37%117.76%-90.62%-91.74%44.7%135.73%-46.5%323.57%157.35%174.65%205.99%-92.6%-159.88%
D&A (Non-Cash Add-back)02.52M2.58M2.66M2.72M2.76M2.8M2.84M2.88M2.91M2.9M2.89M2.88M2.88M2.88M2.21M2.47M2.46M2.46M2.27M
EBIT08.43M-2.7M18.23M10.73M8M5.44M14.86M23.71M-779K-1.24M15.42M8.59M5.64M4.86M-2.03M2.65M12.13M-702K7.15M
Net Interest Income0651K271K-142K-445K-881K-1.08M-1.4M-1.82M-2.13M-2.39M-2.63M-2.65M-2.67M-2.77M-2.76M-2.73M-2.64M-2.65M-2.71M
Interest Income900K831K1M977K1.04M956K1.1M1.23M1.28M1.24M972K719K689K660K537K519K216K65K13K13K
Interest Expense0180K731K1.12M1.49M1.84M2.18M2.62M3.1M3.37M3.36M3.35M3.34M3.33M3.31M3.28M2.95M2.7M2.66M2.72M
Other Income/Expense900K660K401K1K-330K-471K-717K-1.13M-1.47M-1.97M-2.3M-1.99M-2.58M-2.58M-2.82M-15.33M-2.69M-2.63M-2.62M28.02M
Pretax Income6.2M8.24M-3.43M17.11M9.24M6.17M3.27M12.24M20.61M-4.15M-4.59M12.8M6.01M2.31M1.55M-5.31M-293K9.43M-3.37M4.44M
Pretax Margin %11.25%14.59%-7.65%22.67%16.97%11.76%7.1%20.72%25.59%-8.82%-10.5%17.74%10.71%4.24%2.93%-8.09%-0.51%15.84%-7.36%8.01%
Income Tax-200K56K326K3.67M399K310K293K-7.07M291K378K220K536K213K187K147K294K67K57K37K212K
Effective Tax Rate %-3.23%0.68%-9.51%21.45%4.32%5.03%8.97%-57.75%1.41%-9.11%-4.79%4.19%3.54%8.08%9.5%-5.53%-22.87%0.6%-1.1%4.78%
Net Income6M8.19M-3.75M13.44M8.84M5.86M2.97M19.3M20.32M-4.53M-4.82M12.27M5.8M2.13M1.4M-5.61M-360K9.37M-3.4M4.22M
Net Margin %10.89%14.49%-8.37%17.81%16.23%11.17%6.46%32.68%25.23%-9.62%-11%17%10.33%3.9%2.65%-8.54%-0.63%15.74%-7.44%7.63%
Net Income Growth %-32.16%39.86%-226.19%-30.39%-56.47%229.28%161.77%57.36%250.53%-313.03%-443.68%318.84%1710%-77.31%141.17%-232.72%99.19%283.53%-120.59%128.17%
Net Income (Continuing)6M8.19M-3.75M13.44M8.84M5.86M2.97M19.3M20.32M-4.53M-4.82M12.27M5.8M2.13M1.4M-5.61M-360K9.37M-3.4M4.22M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.110.16-0.070.260.170.120.060.390.41-0.09-0.100.260.120.050.03-0.12-0.010.21-0.080.10
EPS Growth %-35.29%33.33%-223.83%-33.33%-58.54%227.93%159.66%50%241.67%-308.44%-436.36%316.67%--78.57%136.85%-220%99.28%261.54%-120.15%126.32%
EPS (Basic)0.120.16-0.070.270.180.120.060.390.41-0.09-0.100.260.120.050.03-0.12-0.010.21-0.080.10
Diluted Shares Outstanding53.12M52.6M50.85M51.52M50.93M50.14M49.91M49.41M49.17M48.29M48.19M48.04M47.82M47.2M47.16M45.81M45.57M45.36M42.21M41.04M
Basic Shares Outstanding51.6M50.94M50.85M50.34M50.34M49.7M49.6M49.1M49.01M48.29M48.19M47.6M47.52M46.76M46.64M45.81M45.57M45.06M42.21M40.99M
Dividend Payout Ratio--------------------